Hypertrophic Cardiomyopathy Panel Test code: 02261 • 10–21 days turnaround time Up to 44 genes

$0.00

Hypertrophic Cardiomyopathy Panel

This panel analyzes genes definitively associated with hypertrophic cardiomyopathy (HCM) as well as genes linked to other inherited cardiomyopathy disorders that may present with clinical features similar to HCM.

Hypertrophic cardiomyopathy (HCM) is characterized by unexplained thickening of the heart muscle, particularly the left ventricular wall. HCM can be associated with a range of cardiac complications, including chest pain, heart failure, abnormal heart rhythms, and cardiac arrest.

Because HCM can have multiple genetic causes and may overlap clinically with other inherited cardiomyopathies, genetic testing can help identify the underlying cause and provide information relevant to medical management.

Individuals with symptoms or clinical findings suggestive of HCM may benefit from genetic testing to:

  • Establish or confirm a diagnosis
  • Identify an underlying genetic cause
  • Clarify potential cardiac risks
  • Guide individualized medical management
  • Support appropriate cardiac monitoring and surveillance
  • Inform risk-reduction strategies
  • Provide information for genetic counseling and family testing

Family Testing:
Asymptomatic individuals with a known familial pathogenic variant may also benefit from targeted genetic testing. Determining whether an individual carries the familial variant may clarify their personal risk of developing HCM and support appropriate clinical evaluation, monitoring, and medical management.

Evaluation for Syndromic Conditions:
This panel also evaluates genes associated with multi-system genetic conditions that may mimic HCM. Individuals who initially appear to have isolated HCM may, through genetic testing, be identified as having a broader genetic disorder in which left ventricular hypertrophy is an initial or prominent clinical feature.

Genetic testing results should be interpreted alongside the individual's medical history, family history, cardiac imaging, and other clinical findings to develop an appropriate management and surveillance plan.